Genetics and proteomics in scleroderma.
The pathogenesis of systemic sclerosis (SSc; scleroderma) is still enigmatic. Genetic, familial, and twin studies suggest that SSc occurs in genetically susceptible individuals. Recent high-throughput technologies, including gene expression profiling and proteomics, have accelerated the rate of information acquired on possible mechanisms involved in SSc pathogenesis. The potential of the data obtained lies in their use for identifying new disease markers, monitoring disease activity, and developing tailored therapies. The result is an era of unprecedented advance that will benefit SSc and many other diseases.
Feghali-Bostwick
Carol A
CA
Division of Pulmonary, Allergy, and Critical Care Medicine, Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, Department of Medicine, 628 NW MUH, 3459 Fifth Ave, Pittsburgh, PA 15213, USA. feghalica@upmc.edu
D000483:Alleles; D023281:Genomics; D000949:Histocompatibility Antigens Class II / Q000235:genetics; D006801:Humans; D007834:Lasers; D042282:Microdissection / Q000379:methods; D020641:Polymorphism, Single Nucleotide; D040901:Proteomics; D012595:Scleroderma, Systemic / Q000235:genetics*; D018433:Twin Studies as Topic
D000949:Histocompatibility Antigens Class II